EH&S is responsive to campus needs during the pandemic. COVID-19 protocols are being coordinated through the UCLA Emergency Operations Center (EOC), Emergency Management Policy Group (EMPG), and UCLA's Future Planning Task Force. Please check Bruins Safe Online for the latest safety information. If you are experiencing an emergency, please call 9-1-1.

Updated On November 5, 2019 - 11:18am

CSP News & Updates- Heparin Shortage

Heparin Shortage

https://www.raps.org/news-and-articles/news-articles/2019/10/fda-us-heparin-supply-not-impacted-by-african-swi

https://www.ashp.org/drug-shortages/current-shortages/Drug-Shortage-Detail.aspx?id=353

Reason for the ShortagE

  • Fresenius Kabi has put heparin on a protective allocation due to a potential shortage of raw ingredient. The letter describing this in detail is available at the following link: https://www.fresenius-kabi.com/us/news/fresenius-kabi-responds-to-a-pote....
  • Hikma did not provide a reason for the shortage.
  • Mylan refuses to provide updated availability information.
  • Pfizer has heparin on shortage due to manufacturing delays.
  • Sagent has heparin on shortage due to manufacturing issues and increased demand.

FDA - Information on shortage

https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Heparin%20Sodium%20and%20Sodium%20Chloride%200.9per%20Injection&st=c&tab=tabs-1